Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1933 2
1934 1
1955 1
1962 3
1963 4
1964 1
1966 3
1967 4
1968 1
1969 3
1970 1
1971 3
1972 4
1974 2
1975 1
1976 2
1977 3
1978 2
1979 6
1980 9
1981 4
1982 4
1983 7
1984 3
1985 7
1986 4
1987 21
1988 13
1989 21
1990 25
1991 19
1992 19
1993 12
1994 18
1995 16
1996 19
1997 17
1998 20
1999 17
2000 13
2001 13
2002 21
2003 18
2004 27
2005 21
2006 24
2007 36
2008 44
2009 46
2010 37
2011 63
2012 60
2013 65
2014 59
2015 58
2016 59
2017 43
2018 53
2019 53
2020 56
2021 19
Text availability
Article attribute
Article type
Publication date

Search Results

1,090 results
Results by year
Filters applied: . Clear all
Page 1
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, Hagiwara M, Li W, Hu Q, Liu S, Yamashita N, Fushimi A, Kui L, Samur M, Yamamoto M, Zhang Y, Zhang N, Hong D, Maeda T, Kosaka T, Wong KK, Oya M, Kufe D. Yasumizu Y, et al. Among authors: kosaka t. Nat Commun. 2020 Jan 17;11(1):338. doi: 10.1038/s41467-019-14219-6. Nat Commun. 2020. PMID: 31953400 Free PMC article.
Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study.
Koga T, Kobayashi Y, Tomizawa K, Suda K, Kosaka T, Sesumi Y, Fujino T, Nishino M, Ohara S, Chiba M, Shimoji M, Takemoto T, Suzuki M, Jänne PA, Mitsudomi T. Koga T, et al. Among authors: kosaka t. Lung Cancer. 2018 Dec;126:72-79. doi: 10.1016/j.lungcan.2018.10.019. Epub 2018 Oct 17. Lung Cancer. 2018. PMID: 30527195
1,090 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page